Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Asia Pacific | 2023

The Asia Pacific heart valve device market has seen a moderately negative impact due to the global COVID-19 pandemic. However, in the long term, the market will be driven by positive results from THV device clinical trials as well as product launches, resulting in robust growth through 2031.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in the Asia Pacific region from 2019 through 2031.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Asia Pacific
The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…